Addex Therapeutics(ADXN)
$4.06-1.23 (-23.25%)
ADXN
Addex Therapeutics financials statements
$4.06
At close:-1.23 (-23.25%)
Want to see ADXN full AI Analyst Report?
Addex Therapeutics (ADXN) Income Statement
86 Followers
Addex Therapeutics Income Statement
Last quarter (Q2 2026), Addex Therapeutics's total revenue was CHF9.91K, a decrease of 66.67% from the same quarter last year. In Q2, Addex Therapeutics's net income was CHF-1.74M. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| CHF 29.97K | CHF 404.10K | CHF 1.61M | CHF 1.42M | CHF 2.92M | |
| CHF 29.97K | CHF 404.10K | CHF 1.61M | CHF 1.42M | CHF 2.92M | |
| CHF 2.84M | CHF 3.16M | CHF 3.86M | CHF 11.96M | CHF 18.42M | |
| Depreciation and Amortization | CHF 8.47K | CHF 260.12K | CHF 305.95K | CHF 323.14K | CHF 347.61K |
| CHF -6.83M | CHF -4.65M | CHF -2.19M | CHF -10.45M | CHF -14.94M | |
| CHF -2.81M | CHF -2.76M | CHF -2.24M | CHF -10.54M | CHF -15.51M | |
| CHF -4.03M | CHF -2.15M | CHF -257.19K | CHF -263.06K | CHF 154.00K | |
| CHF -6.84M | CHF -4.91M | CHF -2.50M | CHF -10.80M | CHF -15.35M | |
| CHF -6.73M | CHF 7.06M | CHF -10.56M | CHF -20.80M | CHF -15.35M | |
| Per Share Metrics | |||||
| Basic EPS | CHF -6.88 | CHF 8.40 | CHF -16.80 | CHF -55.20 | CHF -54.00 |
| Diluted EPS | CHF -6.88 | CHF 8.40 | CHF -16.80 | CHF -55.20 | CHF -54.00 |
| Weighted Average Shares Outstanding | 935.00K | 817.61K | 619.23K | 376.54K | 284.33K |
| Weighted Average Shares Outstanding (Diluted) | 935.00K | 817.61K | 619.23K | 376.54K | 284.33K |
Currency in CHF
